Epione Medicine ApS
Private limited companyCVR 41812052HvidovreActive
Epione Medicine ApS is a private limited company, based in Hvidovre, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2020. Net profit fell 96% from 2024 to 2025, ending at DKK 804k. With 61 employees, the company is about 7 times larger than the industry median. Equity fell to DKK 7.4m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 57% (2024 → 2025), to DKK 13.6m.
- Net profit fell 96% (2024 → 2025), to DKK 804k.
- Equity fell 61% (2024 → 2025), to DKK 7.4m.
Employees
- 30 more employees than a year earlier: 61 (07/2026) against 31 (07/2025).
Management and owners, last 24 months
- New in management: Leon Svejgaard Pedersen (board member, 31/03/2025), Jakob Flinch Skovbjerg (board member, 31/03/2025) and Emil Birk Johannsen (board member, 31/03/2025) (+2).
- New owners registered: Strive Ventures Fund 2 K/S (31/03/2025).
Registrations, last 24 months
- 31/03/2025: Share capital changed from 353,000 DKK to 441,250 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2022–2025 · amounts in DKK thousandEquity and net profit
| 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | – |
| Gross profit | −392 | 2,580 | 31,344 | 13,562 | −56.7% |
| Operating profit (EBIT) | −436 | −264 | 25,476 | 1,844 | −92.8% |
| Profit before tax | −465 | −814 | 24,471 | 1,124 | −95.4% |
| Net profit | −363 | −649 | 19,045 | 804 | −95.8% |
| Total assets | 1,261 | 8,629 | 48,252 | 34,369 | −28.8% |
| Equity | 17 | 29 | 19,074 | 7,378 | −61.3% |
| Liabilities | 1,240 | 8,600 | 28,375 | 26,158 | −7.8% |
| Cash and cash equivalents | 0 | 0 | – | 19 | – |
| Average number of employees | 0 | 6 | 12 | 24 | +100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresEquity fell sharply
Equity fell 61% from 2024 to 2025 (DKK 19.1m to DKK 7.4m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
4 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 25/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 24/06/2025 | The company | PDFXBRL |
| 2023 | 01/03/2023 – 31/12/2023 | 27/06/2024 | The company | PDFXBRL |
| 2022 | 02/11/2020 – 28/02/2022 | 23/08/2022 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 50–199 employees4,467 companies in the comparison | No. 3,589of 4,412 Better than 19% | No. 3,081of 4,466 Better than 31% |
| Same industry and 50–199 employees30 companies in the comparison | No. 29of 30 Better than 3% | No. 28of 30 Better than 7% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 3,141of 33,588 Better than 91% | No. 4,609of 33,687 Better than 86% |
| All companies of type ApS66,508 companies in the comparison | No. 4,107of 66,379 Better than 94% | No. 8,533of 66,505 Better than 87% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Epione Medicine ApSDKK 13.6m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Epione Medicine ApSDKK 804k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Epione Medicine ApSDKK 7.4m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Epione Medicine ApS61
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Jakob SK Holding ApS33.33%
- E.B.J Holding ApS33.33%
- Strive Ventures Fund 2 K/S20%
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Emil Birk Johannsen | CEO | 02/11/2020 |
| Jakob Flinch Skovbjerg | Director | 24/01/2022 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Leon Svejgaard Pedersen | Board member | 31/03/2025 |
| Jakob Flinch Skovbjerg | Board member | 31/03/2025 |
| Emil Birk Johannsen | Board member | 31/03/2025 |
| Steen Ulf Jensen | Chair of the board | 01/07/2025 |
| Nikolaj Friis Krøyer | Board member | 09/04/2026 |
- Founders
- Emil Birk Johannsen
Signing rule: Virksomheden tegnes af Emil Birk Johannsen og Jakob Skovbjerg Kjeldgaard
Address and production units
1 active production unitsKanalholmen 14L
2650 Hvidovre
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Epione Medicine ApS | Kanalholmen 14L, 2650 Hvidovre | 61 | 1026426983 |
Purpose
Virksomhedens formål er engroshandel med medicinalvarer
The purpose is quoted from the register in Danish.
Changes year by year
23 registered events20262 changesaccounts 1 · management 1
- AccountsAnnual report for 2025 published
- ManagementNikolaj Friis Krøyer appointed board member
20257 changesmanagement 4 · accounts 1 · capital 1 · ownership 1
- ManagementSteen Ulf Jensen appointed chair of the board
- AccountsAnnual report for 2024 published
- CapitalShare capital changed from 353,000 DKK to 441,250 DKK
- ManagementEmil Birk Johannsen appointed board member
- ManagementJakob Flinch Skovbjerg appointed board member
- ManagementLeon Svejgaard Pedersen appointed board member
- OwnershipStrive Ventures Fund 2 K/S registered as owner (20%)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20229 changesaccounts 1 · management 1 · capital 2 · ownership 5
- AccountsAnnual report for 2022 published
- ManagementJakob Flinch Skovbjerg appointed director
- CapitalShare capital changed from 180,000 DKK to 353,000 DKK
- OwnershipJakob SK Holding ApS registered as owner (33.33%)
- OwnershipE.B.J Holding ApS registered as owner (33.33%)
- OwnershipE.B.J Holding ApS is no longer registered as owner
- OwnershipE.B.J Holding ApS registered as owner (100%)
- OwnershipEmil Birk Johannsen is no longer registered as owner
- CapitalShare capital changed from 40,000 DKK to 180,000 DKK
20211 changeaddress 1
- AddressMoved to Kanalholmen 14L, 2650 Hvidovre
20203 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Epione Medicine ApS
- ManagementEmil Birk Johannsen appointed ceo
- OwnershipEmil Birk Johannsen registered as owner (100%)
Related companies
Same people in management
- Viaplay Group Denmark Sport A/Svia Steen Ulf Jensen
- Eupry ApSvia Steen Ulf Jensen
- Ah Metal Solutions A/Svia Steen Ulf Jensen
- LegalDesk.dk ApSvia Steen Ulf Jensen
- easyTable ApSvia Leon Svejgaard Pedersen
- Tiimo A/Svia Steen Ulf Jensen
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.